Haemonetics (HAE)

70.17 +0.46  +0.66%  May 29, 8:00PM Go Pro
Watch this stock
View Full Chart HAE Price Chart

Key Stats

Market Cap 1.765B
Revenue Growth 9.78%
Profit Margin 9.54%
Earnings Yield 3.69%
Dividend Yield 0.00%
Earnings Per Share TTM 2.59
PE Ratio 27.11
Price / Sales Ratio 2.425
52 Week High 73.49
52 Week Low 54.99
Beta 0.3656
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 29 1 Reason to Expect Big Things From Haemonetics Fool
May 25 HAEMONETICS CORP Files SEC form 8-K/A, Submission of Matters to a Vote of Security Ho...
May 22 HAEMONETICS CORP Files SEC form 10-K, Annual Report
May 22 Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference PR Newswire
May 10 Listen to $HAE Haemonetics Investor Roundtable - live at 10:00 AM, ondemand after - http://stks.co/3lV7 by earningscast
May 08 $HAE Insider Sale: $1.4M of stock sold by Mark Kroll on May 4, 2012 http://stks.co/3jXC by MarketBrief
May 08 Haemonetics Releases Next Generation of IMPACT® Online Blood Utilization Portal PR Newswire
May 07 Will Haemonetics' Next Quarter Be a Bomb? Fool
May 03 Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference PR Newswire
May 03 $HAE Insider Sale: $1.6M of stock sold by Joseph Forish on May 1, 2012 http://stks.co/3eqG by MarketBrief
May 03 $HAE Insider Sale: $2.5M of stock sold by Mikael Gordon on May 2, 2012 http://stks.co/3eq9 by MarketBrief
Apr 30 4 Stocks Hit 52-Week Highs http://stks.co/3aGr My story via @TheStreet $KFT $CMCSA $MMC $HAE #52WeekHigh by azendrian

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Medical Instruments & Supplies

Haemonetics is a global provider of blood and plasma supplies and services. Founded in Braintree, Massachusetts by Dr. Jack Latham in the 1970s, the company has expanded and has many offices located in 16 countries. They started out producing the containers and bags required for blood collection. From there they have branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. They have recently acquired several companies in an effort to expand their services. These acquisitions include Canadian based Fifth Dimension Information Systems in order to gain entry into the blood and plasma software industry. Further acquisitions include Chicago based Arryx in July 2006, Information Data Management Inc. in January 2007, and Infonale in July 2007.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Haemonetics is up 4.57% over the last year vs S&P 500 Total Return up 1.18%, Mettler Toledo International up 0.20%, and Pall Corporation up 5.97%.

  • HAE Total Returns
  • ^SPXTR Total Returns
  • MTD Total Returns
  • PLL Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring HAE

Did Haemonetics make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

HAE Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
HAE 70.17 +0.46 +0.66% 1.753B
HA 5.68 +0.00 +0.00% 288.15M
GNVC 2.52 +0.02 +0.80% 32.40M
GNTX 23.07 +0.50 +2.22% 3.253B
GNRC 25.39 +0.13 +0.51% 1.715B
GNOM 2.61 -0.39 -13.00% 100.26M
GNMK 4.61 +0.03 +0.66% 93.89M
GNK 3.23 +0.01 +0.31% 141.07M
GNI 65.28 +2.39 +3.80% 94.34M
GNE 7.07 +0.06 +0.86%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close